# Protalix BioTherapeutics, Inc.: Form 8-K, filed Jan 4, 2016

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 8-K
- Filed: 2016-01-04
- Accepted by EDGAR: Jan 4, 2016, 16:30 ET
- Period: 2016-01-04
- Accession: 0001144204-16-073802
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000114420416073802/v428194_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000114420416073802/

## Items reported

- Item 5.08: Item not in the standard list

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000114420416073802/v428194_8k.htm

Filed Jan 4, 2016.
Source: SEC EDGAR, the filing index for accession 0001144204-16-073802. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
